Evidence map›Paper›PMID 27589790›Full record

ReviewNutrients2016

Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update.

Fazlullah Khan, Kamal Niaz, Faheem Maqbool, Fatima Ismail Hassan, Mohammad Abdollahi, Kalyan C Nagulapalli Venkata, Seyed Mohammad Nabavi, Anupam Bishayee

Abstract readReview
In one paragraph

Review in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Current computer-aided drug design · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fazlullah KhanPharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran 1417614411, Iran. fazlullahdr@gmail.com.
Kamal NiazPharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran 1417614411, Iran. kamalniaz1989@gmail.com.
Faheem MaqboolPharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran 1417614411, Iran. faheemthepharmacist@gmail.com.
Fatima Ismail HassanPharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran 1417614411, Iran. pharm.fatee@yahoo.com.
Mohammad AbdollahiPharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran 1417614411, Iran. Mohammad.Abdollahi@UToronto.Ca.
Kalyan C Nagulapalli VenkataDepartment of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, FL 33169, USA. kvenkata@Ularkin.org.
Seyed Mohammad NabaviApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran. nabavi208@gmail.com.
Anupam BishayeeDepartment of Pharmaceutical Sciences, College of Pharmacy, Larkin Health Sciences Institute, Miami, FL 33169, USA. Mohammad@TUMS.Ac.Ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quercetin, a medicinally important member of the flavonoid family, is one of the most prominent dietary antioxidants. It is present in a variety of foods-including fruits, vegetables, tea, wine, as well as other dietary supplements-and is responsible for various health benefits. Numerous pharmacological effects of quercetin include protection against diseases, such as osteoporosis, certain forms of malignant tumors, and pulmonary and cardiovascular disorders. Quercetin has the special ability of scavenging highly reactive species, such as hydrogen peroxide, superoxide anion, and hydroxyl radicals. These oxygen radicals are called reactive oxygen species, which can cause oxidative damage to cellular components, such as proteins, lipids, and deoxyribonucleic acid. Various oxygen radicals play important roles in pathophysiological and degenerative processes, such as aging. Subsequently, several studies have been performed to evaluate possible advantageous health effects of quercetin and to collect scientific evidence for these beneficial health claims. These studies also gather data in order to evaluate the exact mechanism(s) of action and toxicological effects of quercetin. The purpose of this review is to present and critically analyze molecular pathways underlying the anticancer effects of quercetin. Current limitations and future directions of research on this bioactive dietary polyphenol are also critically discussed.

Indexed as

Diet, HealthyAnimalsAntineoplastic AgentsCell Transformation, NeoplasticDNA DamageFruitHumansMolecular StructureNeoplasmsOxidative StressQuercetinSignal TransductionStructure-Activity RelationshipVegetablesAntineoplastic AgentsQuercetinbioavailabilitycancer preventiondietDNA damagepolyphenolsquercetin

Identifiers

PMID27589790
PMCPMC5037516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.